We conclude that the differentiation potential of the human neuroblastoma cell line SH-SY5Y is reduced via CRABP1 up-regulation as a consequence of an increased Aβ42/Aβ40 ratio. This evidence concerns the gene CRABP1 and neuroblastoma.